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1. Introduction  
This chapter will focus on the review of the various bone grafting materials in the market for 
implant dentistry with much emphasis on the fact that they are all second-hand bones (bone 
substitutes) when compared with the autogeneous bone graft which is the gold standard to 
which all bone substitutes are compared. 
Bone grafting implies to the application of autogenous bone or other bone substitute 
obtained from natural or synthetic source to an area of with boney defect. Bone grafting is a 
procedure and should not be confused with bone regeneration which is the actual formation 
of new bone in the grafted defect. Bone grafting does not necessarily lead to bone 
regeneration. It is so important that the clinician and the patient are aware of the difference 
in terminology because of the clinical, scientific and medicolegal implications. 
The use of bone substitutes or bone replacement source has increased tremendously in 
implant dentistry today and will continue to be so because of the unavailability of 
autogenous bone from the intra-oral site in most situation and patients are becoming more 
and more tolerant to clinicians harvesting bone from the extra-oral site such as the iliac crest 
or the tibial tuberosity. 
The mechanisms available for bone regeneration will be fully described and classification of 
bone substitutes under these mechanisms will be attempted so as to assist the surgeon make 
a decision regarding which bone substitute to be used for  pre-implant, intra-implant 
surgery  and post-implant bone grafting and regeneration. 
Theses previously mentioned bone regeneration mechanisms are actually positive 
mechanisms (osteogenesis, osteoinduction and osteoconduction). The author will introduce 
a newly discovered mechanism called the osteo-obstructive mechanism as a negative bone 
regeneration mechanism. This osteoobstructive mechanism was accidentally discovered by 
the author on single photon emission computerized tomography (SPECT) with histologic 
correlation during animal experiment to validate bone grafting technique and substitutes in 
the Ogunsalu sandwich bone regeneration technique. This osteoobstuctive mechanism has 
been histologically confirmed to be due to foreign body reaction. 
In this chapter bone grafting will be mentioned distinctly from bone regeneration, similarly 
bone substitute (second -hand bone) will be distinctly separated from autogeneous bone graft. 
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The best GTR-membranes which will be preferably used with bone substitutes will be 
mentioned against the background of a new bone grafting technique called the Ogunsalu 
sandwich technique. 
Finally the only available method for the qualitative and quantitative validation of bone 
substitutes and their comparism with one another will be described, in conjunction with 
histologic correlation. This method utilizes SPECT as a dynamic way for assessing 
osteoblastic activity after bone grafting and during bone regeneration. 
1.1 Classification, types and source 
This has been dealt with poorly in most standard textbook and as such I would attempt to 
adjust the existing classifications and sources. The source of bone graft could be autogenous or 
non autogenous with the autogenous bone source being the gold standard by which the non 
autogenous sources are to be compared for efficiency in effecting bone regeneration in the 
desired site. The autogenous bone can be derived from both intraoral or extra-oral sites. The 
intra-oral site includes the, chin, maxillary tuberosity, the body of the mandible , the ramus of 





Fig. 1. Bilateral, multilobulated oral tori of the mandible. 
The non-autogenous source are therefore second-hand in comparism to the autogenous 
source, for this reason I will call them the second-hand bones or bone grafting material(bone 
substitutes). Autogenous bone used for bone grafting should as such not be called bone 
grafting materials but rather a bone graft source. 
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The second hand bones are basically the allograft, alloplast of which the commercially 
available xenograft and the synthetic graft materials are generally considered a subgroup of 
the alloplastic bone grafting source. 
The figure 2 shows the classification of bone grafting sources taken from the Glossary of 
implant dentistry II, published by the international congress of oral implantologists. I would 
however suggest that the classification shown in figure 3 be considered a reasonable 
variation of the former classification. 
The origin of the bone graft will dictate the mechanism of its action with the understanding 
that none of them is osteogenic in action like the autogeneous bone graft source, which is an 
organic bone source harvested from the patient. This autogeneous bone also additionally 
forms bone by osteoinduction and osteoconduction, the two mechanisms ascribed to the 















Fig. 2. Showing a reasonable classification of bone grafting source 
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Fig. 3. Showing a much better classification of bone grafting source 
1.2 Mechanism of action of bone substitutes 
Bone grafts can effect bone replacement through three different mechanisms: osteogenesis, 
osteoinduction and osteoconduction (Misch and Dietsh 1993). Osteogenesis refers to organic 
material capable of forming bone directly from osteoblast (Misch and Dietsh 1993 and Marx 
and Saunders 1986). An osteogenic graft can therefore be said to be derived from or 
composed of tissues involved in the natural growth or repair of bone. It is for this reason 
that they can even encourage bone formation in soft tissues or activate more rapid bone 
growth in bone sites (Garg 2004, Wood and Moore 1988). Osteoinductive materials are 
capable of inducing the transformation of undifferentiated meseneymal cells into osteoblasts 
or chondroblast and enhance bone growth or even grow bone where it is not expected 
(Misch and Dietsh 1993). Urist (Urist 1980 and Urist 1965) recognized the mechanism as 
dependent upon many factors which includes specific proteins (e.g. bone morphogenic 
proteins [BMPs] located primarily in cortical bone. Osteoconduction is characteristic of a 
material (often organic) which permits bone apposition from existing bone and requires the 
presence of bone or differentiated mesenchymal cells (Rejda, Peelen and deGroot 1977 and 
Jarcho 1981). Osteoconduction provides a physical matrix or scaffolding suitable for the 
deposition of new bone. Osteoconductive graft are conductive to bone growth and allows 
bone apposition from existing bone, but do not produce bone formation themselves when 
placed within soft tissue (Garg 2004, Wood and Moore 1988). The healing of dental implants 
with a direct bone contact has been described as an osteoconductive process (Albrektsson 
1985, 129-143). 
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Transplanted osteogenesis is another term for bone grafting. This term emphasizes that bone 
is dynamic and forms by cellular regeneration, which produces osteoid that becomes 
mineralized. A graft is not a solid bone block that heals into place (Garg 2004 and Marx and 
Garg 1998). Bone grafting is accomplished through osteogenesis, osteoinduction and 
osteoconduction (Lane 1995, Frame 1987, Pinholt, Bang and Haanaes 1991, and Lancet 1992). 
Osteogenesis refers to the formation and development of bone by osteocompetent cells. 
Osteogenic  graft materials which are derived from or comprised of tissue involved in the 
natural growth and repair; it can encourage bone formation in soft tissues, and stimulates 
faster bone growth in bone implant site, whereas osteoinduction is the process of activating 
osteogenesis by recruiting cells from the surrounding natural bone that then differentiate 
into bone-forming cells. Osteoinductive grafts can enhance bone generation, sometimes even 
resulting in the extension or growth of bone where it is not normally found (Marx and Garg 
1998). Osteoconductive grafts are those that act as nonviable scaffold on to and within which 
the patient’s own natural bone grows. They are conductive to bone growth and allow 
apposition from existing bone but do not produce or trigger bone formation themselves 
when placed in soft tissue. 
The table below shows the properties of the various types of bone graft sources in terms of 
mechanism of action with regards to bone regeneration. 
 
Properties of various types of bone graft source. 
Osteoconductive Osteoinductive Osteogenic 
Alloplast + – – 
Xenograft + – – 
Allograft + +/– – 
Autograft + + + 
Table 1. Showing the properties /mechanism of action for various bone source 
It is important to note that all bone grafting materials have one or more of these three modes 
of action. Mixing of bone grafting substitutes can assist in bringing about a desired 
combination of modes of action for bone formation. For example Bio-Oss which is basically 
osteoconductive can be mixed with allograft as a deliberate or circumstantial cocktail to 
effect both osteoconductive and some osteoinductive properties. Because of making up the 
quantity of bone required in defects that definitely will benefit more  from autogenous bone 
graft, any bone substitute can be mixed with autogenous bone graft to additionally effect all 
the mechanisms of action of bone regeneration attributed to autogenous bone graft. 
Osteogenesis can form bone more rapidly and in conditions which have the least amount of 
bone. Autogenous bone is suggested even when additional operating time and surgical site 
preparation is required when limiting factors exist. Osteoconductive materials require the 
most ideal condition to grow bone, yet are the easiest material to obtain and manipulate. 
The amount of remaining host bone in the region and mode of action and physical 
characteristic of available graft materials must be considered prior to the selection of any 
one type or combination for use in implant dentistry (Misch and Dietsh 1993). 
Osteogenesis, osteoinduction and osteoconduction are all positive mechanisms of bone 
regeneration with Osteogenesis being the fastest and most reliable. Bone substitute that 
regenerate bone via the osteoconductive mechanism are the least efficient.  
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In his classical experiment using animal model, Ogunsalu et al accidentally discovered the 
negative mechanism that will prevent bone regeneration (Ogunsalu 2009). This new 
mechanism called osteobstruction will be discussed in detail towards the end of the chapter. 
2. Review of the literature on bone replacement source 
The three primary types of bone graft material are autogenous bone, allograft and alloplast 
of which commercially available xenografts are generally considered a subgroup (Garg 
2004). The mechanism by which these graft materials work normally depends on the origin 
and composition of the material (Misch and Dietsh 1993 and Lancet 1992). Autogenous 
bone, an organic material harvested from the patient, forms new bone by osteogenesis, 
osteoinduction and osteoconduction. Harvested from the cadavers, allografts which may be 
cortical or trabecular, have osteoconductive and possible osteoinductive properties (Garg 
2004), but definitely they are not osteogenic. The alloplasts, which may be composed of 
natural or synthetic material, are typically only osteoconductive (Garg 2004).  
In determining what type of graft material to use, the clinician must consider the 
characteristics of the bony defect to be restored (Misch and Dietsh 1993). In general, the 
larger the defect to be restored, the greater the amount of autogenous bone required. For 
small defects and for those with three to five bony walls still intact, alloplast may be used 
alone or with allografts.  For relatively large defects or those with only one to three bony 
walls intact, autogenous bone must be added to any other type of graft material being 
considered. One of the complications during augmentation procedures with any grafting 
material is soft tissue ingrowths; it is for this reason that guided bone regeneration (GBR) 
using resorbable or non-resorbable membrane is to be employed (Schopper, Goriwoda, 
Moser, Spassova, Watzinger and Ewers 2001). 
With regards to Maxillary sinus lift procedure, various materials including autogenous bone 
(Kent and Block1989, Jensen, Simonsen and Sindet- Pederson 1990, Reghoebar, Browne, 
Reintsena and Van Dort 1993, Adell R, Lekholm, Grondahl, Branemark, Lindstorm and 
Jacobsson 1990, Kahnberg, Nystrom and Bartholdsson 1989 and Nystrom, Kahnbourg  and 
Gunne 1993), bone allograft (Misch and Dietsh 1993,Lane 1995, Lancet 1992, Wood and 
Moore 1988, Rummelhart, Mellonig, Gray and Towle 1989, Mellonig 1987, Tatum et al. 1993 
and Tatum 1996) and alloplasts such as tricalcium phosphate (TCP), resorbable and non 
resorbable hydroxyapatite (Misch and Dietsh 1993, Rummelhart et al. 1989, Fetner, Hartigan 
and Low 1994, Schepers et al. 1993 and Smiler et al. 1992) bovine bone derivative (bovine-
derived mineralized deprotinised bone) (McAllister et al. 1999) and bioactive glasses are 
used. It is important to note that an ideal graft is non-toxic, non-antigenic, non-carcinogenic, 
strong, resilient, easily fabricated, able to permit tissue attachment, resistant to infection, 
readily available and inexpensive (Wagner J 1989). 
Autogenous bone which has long been considered the gold standards of grafting materials 
is currently the only osteogenic graft material available to clinical practitioners. When 
utilized for bone grafting autogenous bone heals into growing bone through all these modes 
of bone formation; these stages are not separate and distinct, but rather, overlap each other 
(Misch and Dietsh 1993). Autogenous bone can be harvested from extraoral sites such as the 
iliac crest or tibial plateau and intraoral sites sites such as the mandibular symphysis, 
maxillary tuberosity, ramus or exostosis (particularly the oral tori) (Misch and Dietsh 1993, 
Koole, Bosker, van der Dussen 1989 and Garg 1996). 
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It is well documented that less resorption is associated with the use of mandibular bone 
graft than with iliac crest grafts (Koole, Bosker, van der Dussen 1989). The use of expanded 
polytetrafluoroethylene (e-PTFE) membranes or slowly resorbable collagen membranes has 
been documented to enhance bone grafting (Buser, Dula, Hirt, Schenk et al.1996). 
Furthermore, bone graft obtained intraorally would generally result in less morbidity; 
however intraoral  bone sites provides a significantly smaller volume of bones than do 
extraoral sites such as the iliac crest or tibeal plateau. The volume and type of regenerated 
bone needed for the site, will dictate the optimal donor site. The posterior iliac crest 
provides the greatest amount of bone (Koole, Bosker, van der Dussen 1989). 
As previously stated, the autogenous bone graft is highly osteogenic and best fulfils the 
dental grafting requirement of providing a scaffold for bone regeneration (Hislop, Finlay 
and Moos 1993). Significant disadvantages associated with the use of autogenous bone 
include the need for a second operative site, resultant patient morbidity and in some cases 
the technical difficulties relating to obtaining a sufficient amount of graft material (this 
particular disadvantage relates to intraoral donor sites). In fact, it is these disadvantages and 
limitations that have lead to the development of less suitable alternatives such as allograft 
and alloplasts (Lane 1995, 36, Rummelhart, Mellonig, Gray and Towle 1989). 
Autogenous bone graft forms the rigid scaffold which supports teeth and implants. It is 
composed of organic and inorganic structures. Resilience, toughness, and continuity are 
related to collagen, of the organic component. Stiffness, hardness and rigidity are 
characteristics of the inorganic aspect; a crystalline, ceramic-like material which is primarily 
hydroxyapatite (HA). This inorganic matrix contains organic components of osteocytes, 
osteoclasts, osteoblasts, osteogenic signaling proteins and various amount of mesenclymal 
tissue. Without any doubt, autogenous bone is the only osteogenic material (Misch and 
Dietsh 1993) and the various sites for harvesting autogeneous bone include intra-oral sites 
such as the chin, ramus, body of the mandible, maxillary tuberosity, oral tori and other 
exostosis, zygomatic buttress. The extra-oral sites are; tibial tuberosity, iliac crest (Misch and 
Dietsh 1993 and Garg 2004). Banked debris during implant osteotomy preparation is also 
another source of autogenous bone graft which is usually omitted by various authors (Misch 
and Dietsh 1993, Garg 2004, Koole, Bosker, van der Dussen 1989 and Garg 1996). 
As shown in Figure. 4, grafted autogenous bone heals in three phases. During the first 
phase, the surviving cells are responsible for the formation of osteoid by osteogenesis. They 
are most active within the first four weeks after bone grafting (Marx and Saunders 1986, 347- 
428). The blood vessels from the host bone and the connecting tissue invade the graft. Bone 
cells from the host tissue follow the blood vessels and remodel the graft by a coupled 
resorption and formation phenomenon as reported by Roberts et al (Roberts et al. 1987). The 
BMP derived from the mineral matrix of the grafted bone through the resorbing action of 
osteoclast, acts as a mediator for the second phase (Urist 1980 and Urist 1965). The BMP and 
other proteins must be released prior to the osteoinduction cycle. Phase three occurs as the 
inorganic component of bone acts as a matrix and source of minerals during replacement of 
the matrix by the surrounding bone and resembles an osteoconductive mode of action. The 
three phases overlaps in the time sequence and are not separate phases of growing bone 
from the grafted autogenous material.  
Grafted autogenous bone can be trabecular (cancellous), cortico-cancellous or cortical. The 
cancellous portion of grafts provides the cells for osteogenesis and survives best when a 
blood supply from the host bone is readily available. Cortico-cancellous block grafts permit  
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Phase 1 Osteogenesis 
 
Surviving cells - 4 weeks --> osteoid 
Phase 2 Osteoinduction 
 
BMP release - 2 weeks  -->  6 months 
 
Peaks at 6 weeks 
Phase 3 Osteoconduction 
Inorganic Matrix - Space fillers 
Cortical plate - Guided Tissue Regeneration 
(GTR) 
since it acts as a barrier to soft tissue invasion. 
Fig. 4. Grafted autogenous bone healing, depicting the three phases of bone healing. 
contouring and adaptation of the graft to the recipient bed anatomy. It is important however 
to quickly point out at this stage that the Ogunsalu sandwich bone regeneration technique 
(Ogunsalu 2009 ) will permit the cancellous portion of the autogeneous bone graft to be 
contoured and adapted to the recipients bed anatomy also. The trabecular portion is placed 
on the host bone and the cortical aspect is positioned on the surface of the graft. The 
cancellous portion is primarily responsible for the living bone cells and osteogenesis and 
therefore placed closest to the new blood vessels which arrive from the host bone and enter 
the graft at a rate of 0.5mm/day (Marx and Saunders 1986, 347- 428). The cortical graft 
supports osteogenesis only from the surviving cells (fewer than trabecular bone) and also 
provides more of the BMP compared with trabecular bone for the second osteoinductive 
phase (Longacre, Converse and Knize 1977). The cortical aspect also provides a more 
resistant scaffold for the third osteoconductive phase. In addition, it may act as a barrier to 
soft tissue invasion (thus excluding the need for a GTR membrane) and provide an extended 
period for blood vessels to enter the graft from the host bone (Misch and Dietsh 1993). 
Allografts are obtained from cadavers or from patients’ living relatives or non-relatives. 
Basically these bone grafts are of the same species but different genotypes. After processing, 
they are stored in bone banks. The advantages of allografts are availability, elimination of 
the donor site in the patient, decreased anesthetics and surgery time, decreased blood loss, 
and fewer complications. However, it is associated with some disadvantages which relate to 
bone tissues coming from another individual. Consequently the medical history must be 
thoroughly checked to eliminate donors with history of infection, malignant neoplasm’s, 
degenerative bone diseases, hepatitis B or C, sexually transmitted diseases, autoimmune 
disease and other problems which affects the quality of the bone and the health of the 
recipient (Fonseca et al. 1986). 
There are four main types of bone allografts: frozen, freeze-dried (lyophilized), 
demineralized freezed dried bone (DFDB), mineralized deproteinized and irradiated 
allograft. Fresh allografts are the most antigenic; freezing or freeze-drying the bone 
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significantly reduces its antigenicity (Lancet 1992).  Allografts are not osteogenic and so, 
bone formation takes longer and results in less volume than can be achieved with 
autogenous grafts (Misch and Dietsh 1993). Allograft is said to form bone by osteoinductive 
effect on surrounding undifferentiated mesenclymal cells in the soft tissue over the graft as 
the blood vessels grow into the graft. It may also form bone by the osteoconduction 
phenomenon when the host bone resorbs the material and grows into its scaffold.  
Freeze dried bone allograft (FDBA) can be used in either a mineralized or a demineralized 
(DFDBA) form. Demineralization removes the mineral phase of the graft material and 
possibly exposes the underlying bone collagen and growth  factors such as the bone 
morphogenic proteins (BMPs) which has been implicated as a factor that increases the 
osteoconductive capabilities of allografts (Lane 1995, Acil et al. 2002 and Wikesjo et al. 2002). 
Freeze dried bone allograft hardens faster than DFBA because it is mineralized. Clinical 
studies have shown that grafting of the sinus with DFDBA alone results in the presence of 
dense connective tissue after six months whereas grafting with FDBA results in the presence 
of new bone formation (Meffert 1998). The clinical and histological study conducted by 
Feuille, Knapp, Brunsvold et al in 2003 showed that sites grafted with FDBA and subjected 
to GTR by coverage with an e-PTFE barrier can yield predictable result when augmenting 
alveolar ridges prior to placement of implants (Feuille et al 2003). MTFC (Dentsply friadent 
Ceramid, Lakewood Co.) and puros (Zimmer dental, Carlsbond, CA) are examples of 
manufacturers’ allografts. The MTF is an allogenic freeze-dried bone that is available in both 
mineralized and demineralized forms. The FDBA is more effective than DFDBA in the 
following situations: repair and restoration of fenestrations, minor ridge augmentation, 
fresh extraction site filler, sinus lift, bone grafting and in the repair of dehiscence’s and 
failing implants. The Puros is an allogenic graft material that has been subjected to a well-
tested processing method to reduce antigenicity and to minimize any cross infection with 
HIV or Hepatitis virus (Masullo 1995). Puros which is solvent-preserved (in comparison 
with the freeze-drying) to extract the water component has been demonstrated to 
osseointegrate as effectively as cryopreserved material and to be equally biotolerable 
(Gunther et al 1996). This material has been very promising with regards to good bone 
formation and repair (Sener et al. 1998, Becker et al. 1996, Dalkyz et al. 2000 and 
Alexopoulau et al 1998). 
Moreover, because the water component is removed by solvents rather than by cryo-
dehydration, which can alter the mineral as a result of volume expansion that occurs during 
the transition from the liquid to the solid phase, the mineral matrix is said to remain intact 
(Gunther et al 1996). This mineral also has both the mineral and collagen phases of allogenic 
tissues. 
The use of DFDBA as a graft material continues to be questioned because of various reports 
showing that it is unpredictable in regenerating new bone. In one study in humans, for 
example, the DFDBA particles were found to be surrounded by uninflammed connective 
tissue (Brugnami et al. 1996). However, a more recent study (Feuille et al 2003) showed 
positive result with the use of DFDBA and a cell occlusive membrane. Incorporation of the 
DFDBA particles was observed in new bone that contained lacunae with osteocytes 
(Brugnami et al. 1996). The use of FDBA in this study instead of DFDBA might have yielded 
a more favorable outcome in terms of new bone regeneration. It is believe that BMPs and 
other non-collagenous protein in the expressed matrix are responsible for the 
osteoconductivity of DFDBA (Garg 2004). The osteoconductivity however, depends on the 
www.intechopen.com
 Implant Dentistry – The Most Promising Discipline of Dentistry 
 
138 
quality and quantity of the bone matrix in the graft material (Zhang, Powers, and 
Wolfinbarger 1997). Furthermore, studies have shown that different samples from the same 
bone bank and also different samples from different bone banks of the DFDBA can display 
different osteoconductive activity (Schwartz et al 1996). 
To date, there are no widely acceptable tests or guarantee to ensure that DFDBA materials 
meet any minimum standards for osteoinductive properties; it is for this reason that this 
graft material had been avoided by many surgeons when bone grafting is considered. 
Invitro and in vivo assays have been utilized to a limited extent to assess the 
osteoconductivity of DFDBA (Zhang, Powers, and Wolfinbarger 1997). 
DFDBA can be combined with other materials that have the potential to enhance bone growth. 
For example, the use of tetracycline with a DFDBA allograft has been studied; however, no 
benefit was derived from reconstituting the DFDBA particles in tetracycline hydrochloride 
during grafting of osseous defects (Masters et al. 1996).  Osteogenin, a bone-inductive protein 
isolated from human long bones has been combined with DFDBA and studied in the 
regeneration of intrabony periodontal defects. Although this combination generated new 
attachment apparatus and component tissues more positively, it did not have any additional 
positive effect on new bone regeneration (Bowers, Felton and Middleton 1991).In another 
study, which compared Osteofil (Regeneration Technologies, Alachula, FL) a DFDBA with 
Grafton (osteotech, Eatontown, NJ) another DFDBA which, forms bone via osteoconductivity, 
suggested that the graft processing methods could represent a greater source of variability 
than do differences among donors (Takikawa et al. 2003). 
Irradiated cancellous bone (Rocky Mountain Tissue Bank, Denver, Co.) has also been used 
as a substitute graft material for autogenous bone (Tatum, Lebowitz, Tatum and Borgner 
1993, Tatum 1996). This is trabecular allograft obtained from the spinal column and treated 
with between 2.5 and 3.8 megarads of radiation. It has been shown that among all available 
allograft, irradiated bone is most similar to autogenous bone in terms of demonstrating 
rapid replacement and consistent establishment of a reasonable ratio of new bone with less 
expense and morbidity than that associated with autogenous material (Tatum, Lebowitz, 
Tatum and Borgner 1993 and Tatum 1996). Unfortunately, because of lack of further work in 
this area, the use of this material is not recommended (Garg 2004). 
Gendler (Gendler 1986) in 1986 demonstrated by experiments that perforated demineralized 
bone matrix was a new form of osteoinductive material. Osteoinduction which is defined as 
transformation of non osseous connective tissue cells into osteogenic and chondrogenic cell, is 
an important biological process whose contribution  to the physiology of bone remodeling and 
fracture healing at that time had only began to be appreciated (Mckibbin 1978 and Peck 1981). 
In his unique experiment, Gendler demonstrated that subcutaneous implantation of 
perforated decalcified bone matrix (PDBM) induced multiple centers of endochondral 
osteogenesis with subsequent resorption of bone matrix and replacement by new bone. He 
therefore suggested that PDBM should be a useful research model to study osteoinduction 
and in the clinical management of orthopedic and reconstructive surgery for the filling of 
bone defects and stimulation of fracture healing (Gendler 1986). 
Alloplast, xenografts and tissue-engineered materials are another group of bone graft 
substitutes. These include the deorganified bovine bone, synthetic calcium phosphate 
ceramics (e.g. hydroxyapatite, TCP) and calcium carbonate (e.g. Coralline). These ceramics 
form the new bone strictly by osteoconduction (Misch and Dietsh 1993 and Meffert et al. 
1985) with the new bone formation taking place along their surface. 
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Basically alloplastic materials for bone growth are synthetic or deorganified biocompatible 
materials developed to cover a broad range of clinical applications for bone growth or soft 
tissue support. They come in a variety of textures, sizes and shapes and readily available 
and are mostly ceramics (Misch and Dietsh 1993). 
Ceramic alloplasts may be bioinert or bioactive. Inert ceramics do not bond with the host 
bone. The relationship consists of an intimate mechanical contact which permits force 
transfer. They are rarely used as bone augmentation materials, but often are used as 
endosteal implants (e.g. aluminum oxide [Al2 O2 ] and titanium oxide [TiO2]) as previously 
mentioned; the mode of bone formation for these ceramics is osteoconduction. Sub 
categories of bioactive calcium phosphate ceramics includes synthetic TCP and dense HA 
and those derived of natural origin (corallin or deorganified bovine and human bone). A 
chemical contact between the host bone and grafted material may be developed as well as 
possible stimulus for bone activity (Le Geros 1988).These materials exhibit good 
compressive strength, but poor tensile strength (similar to bone) (Le Geros 1983). 
Additionally, particle size, porosity, chemical structure and composition of the bioactive 
ceramics greatly influence the resorption rate of the material and may be another method of 
describing bioactive materials (Misch and Dietsh 1993). The bioactive ceramics differ greatly 
in resorption properties.  Although difference in the biologic response of implanted bone 
substitute occurs, all have been recommended for augmentation (Masters 1988 and Le Geros 
1988). TCP can be used with osteogenic or osteoinductive materials to improve the handling 
characteristic of the graft during placement (Misch and Dietsh 1993). Both hydroxyapatite 
and TCP are safe and well tolerated. 
Cerasorb (Curasan, Kleinostheinon, Germany) is a beta-tricalcium phosphate (beta-TCP) 
material that has been certified for use in bone defect regeneration in the entire skeletal 
system. It is also certified in Europe as a synthetic carrier of the patient’s own platelet rich 
plasma. This material is resorbed completely and is a generally replace by natural bone in 
three to twenty four month period, depending on the type of bone. 
Hydroxyapatite (HA) is the principal inorganic component of the calcified tissues in the 
human body and has calcium to phosperous ratio of 10:6. Its crystallographic similarity to 
the bone mineral apatite allows bone growth and contact when implanted in hard tissue 
(Misch and Dietsh 1993). Various types of HA can be distinguished according to physical or 
chemical characteristics. Physical properties are the surface area or form of the product 
(block, particle), porosity (dense, macroporous, microporous) and crystallinity (crystal or 
amorphous), chemical properties are related to the calcium-to- phosphorous ratio, elemental 
impurities (such as carbonate) ionic substitution in HA and the PH of the surrounding 
region (ToFe, Watson and Bowerman 1991). These properties all play a role in the rate of 
resorption and clinical application of HA material (ToFe, Watson and Bowerman 1991). The 
larger the particle size, the longer the material will remain at the augmentation size. Thus 
75um particle will resorb more rapidly than 3000um particles. The porosity of the calcium 
phosphate also impacts on the resorption rate. Tofe et al (ToFe, Watson and Bowerman 
1991) reported on the porosity of dense, macroporous and microporous HA. Dense HA may 
lack any macro or microporousity within the particles (Misch and Dietsh 1993). The longest 
resorption rate occurs with the dense HA type since osteoclasts may only attack the surface 
and cannot penetrate the dense material (Misch and Dietsh 1993).  The greater the porosity, 
the more rapid the resorption of the graft material. The crystallinity of HA also affects the 
resorption rate of the material. The highly crystalline structure is harder for the body to alter 
and resorb. The crystalline form of HA has been found to be very stable over the long term 
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under normal conditions while the amorphous structures are more likely to exhibit 
resorption, The less crystalline the material, the faster its resorption rate (Le Geros 1983).  
The purity of HA bone substitute may also affect the resorption rate. The resorption of this 
bone substitution requires living cells, similar to the modeling/ remodeling process of living 
bone with the coupled resorption/ formation process. A solution-mediated resorption 
permits the dissolution of the material by a chemical process. Impurities in bioactive 
ceramics, such as calcium carbonate, permits solution-mediated resorption which then 
increases the porosity of the bone substitute. It is said that corallin HA does not demonstrate 
micropores around the larger holes, the HA has carbonates incorporated within the 
material, which hastens the resorption process (ToFe, Watson and Bowerman 1991).  
The pH in the region in which the bone substitute is placed also affects the rate of resorption 
of HA. As the pH decreases (e.g. from the infection in the bone), the HA components of 
living bone and phosphates resorbs by the solution-mediated process. Bone, dense HA, 
macroporous HA, microporous HA, crystalline HA or amorphorous HA may all resorbs 
within a two week period. 
Physical properties should determine the type of HA selected for residual ridge augmentation. 
Dense, crystalline, large particle size HA can be used for ridge augmentation. Dense HA 
particles may also act as space filler or modifier of soft tissue contours under pontics of a 
fixed partial denture or around implants (Jarcho 1981). Dense crystalline HA cannot be 
easily cut and should not be placed in bone defects when the insertion of endosteal implants 
is planned in the future, in addition when an implant is in contact with dense crystalline 
HA, the material cannot grow into or attach itself to the implant surface. As a result, less 
percentage of inert bone implant bone implant contact occurs and compressive forces cannot 
be transmitted as well to the HA particle-implant interface. This factor will increase the 
amount of force generated to the remaining bone contacting the implant. 
As the resorption rate of macroporous HA is generally greater than thirty six months, it is 
used where a more long-term matrix is desired (e.g. ridge augmentation or subantral 
augmentation). The resorption rate of microporous HA (six to twelve months) is compatible 
with applications where scaffold is needed within bone during the first several months of 
healing, but where living bone is desired in the near future.  
Tricalcium phosphate (TCP) has calcium to phosphorous ratio of 3:2, and is intended to 
provide a scaffold for initial bony proliferation. TCP has been reported to act as short-term 
biologic filler which is resorbed over time by osteoclasts and replaced by living bone cells 
which grow directly in contact with the material without any encapsulation process (ToFe, 
Watson and Bowerman 1991 and Heimke and Griss 1983). The resorption of TCP and its 
replacement by new bone occurs through various mechanisms. The process seems to be 
very dependent upon the material characteristics, primarily chemical structures, porosity 
and particle size. These characteristics are closely related to manufacturing processes (Swart, 
Rejda and de Groot 1979). 
TCP is prepared by sintering processes. It is very sensitive to heat and sterilization, which 
may change its chemical structure and alter its properties, including resorption rate (Le 
Geros 1988). It can be used in combination with osteogenic and or osteoinductive materials 
because it provides improved handling characteristics to the graft during placement. In 
addition to Cerosorb®, which is mentioned above as β-TCP, other commercially available 
TCP products are; Calciresorb® (Ceraver Osteal, Paris, France), Synthograft (small size and 
dense) and Augmen (larger size and dense) (Miter, Warsaw). 
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Bovine-derived anorganic bone matrix materials (xenogenic alloplast) are utilized for bone 
grafting. An example of this is Bio-Oss (Osteohealth, Shirley, NY) which is anorganic bovine 
bone that has been chemically treated to remove its organic component. 
After the Bio-Oss is sterilized, it can be used as a graft without causing a host immune 
response (Hislop, Finlay and Moos 1993). Bio-Oss is osteoconductive (Hislop, Finlay and 
Moos 1993 and Pinholt, Bang and Haanaes 1991) and over time, the graft undergoes 
physiologic remodeling and becomes incorporated into the surrounding bone. This type of 
bone graft can be used alone or in combination with barrier membrane in periodontal 
defects, dehiscences and fenestrations around implants and in small sinus osteotomies. In 
large alveolar ridge deficiencies, anorganic bone can be combined with autogenous bone for 
successful augmentation. Anorganic bone has been utilized in the treatment of intra bony 
defects, and for maxillary sinus augmentation and treatment of peri-implantitis (Garg 2004). 
Bovine bone substitutes are widely used for treating osseous defects, however, there is a risk 
of transmitting bovine spongiform encephalopathy to human (Will 1999, Scott et al. 1999 
and Vedrager 1999). As these materials are routinely and successfully utilized in surgical 
dentistry and orthopedic surgery, careful risk assessment has to be done. Bio-Oss and 
osteograft are bovine derived bone substitute which are processed from veterinary certified 
cows from the USA, a country that is known to be free of BSE-cases. Consequently it is 
unlikely that the starting material for the manufacturing of Bio-Oss or osteograft contains 
prions. However, it has recently been questioned whether the U.S.A. can still be considered 
as a BSE-Free country. 
(http://europa.eu.int/com/dgs/healthconsumer/library/press/press66_en.html)  
The issue has become more urgent as many biomaterial scientists, dental and orthopedic 
surgeons are getting more concerned about the bio-safety of biomaterials from bovine 
origin. There is an increasing interest in the analysis of the risk of transmitting BSE through 
grafting materials derived from the bovine bone.  The theoretical risk assessment has been 
done according to a model proposed by the German Health Authority 
(Bundesgesundheitsamt 1994 and Bundesgesundheistamt 1996). This was done before for 
osteograft /N based on a model published in 1994 (Bundesgesundheitsamt 1994).  Wenz et 
al in their publication of 2001 on the analysis of the risk of transmitting bovine spongiform 
encephalopathy (BSE) through bone grafts derived from bovine bone concluded that 
theoretical and experimental data indicate that the use of these materials does not carry a 
risk of transmitting BSE to patients (Wenz, Oesch and Horst 2001). 
PepGen P-15 (Dentsply Friadent Ceramed) is another form of bovine-derived hydroxyapatie 
which is enhanced and contains an added synthetic short-chain peptide p-15.  This 
component mimics the cell-binding domain of type I collagen which is responsible in 
natural bone for cell migration, differentiation and proliferation (Similer 2001). PepGen P-15 
may provide the benefit of a synthetic graft containing an inorganic and an important 
organic component that together may mimic autogeneous bone in graft sites. This material 
has been reported to provide enhanced bone formation in a shorter time compared with the 
other bovine-derived hydroxyapatite plus DFDBA graft material traditionally used for sinus 
augmentation (Krauser, Rohrer and Wallace 2000). Another study indicated that enhanced 
bone formation and faster particle resorption can occur with Pep-Gen P-15 flow (PepGen p-
15 particles suspended in biocompatible inert hydrogel consisting of sodium 
carboxymethyl-cellulose, glycerol and water) compared with the pep-Gen P-15 particles 
(Hahn, Rohrer and Tofe 2003).  
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Recently the bioactive glass ceramics have emerged as a bone grafting material. Bioglass (US 
Biomaterials, Jersey City, NJ) is composed of calcium salts and phosphate in a proportion 
similar to that found in bone and teeth, as well as sodium salts and silicon, which are 
essential for bone to mineralize. Bioglass is an amorphous material which is deliberately not 
manufactured in the crystalline form (to strengthen the material) because the developers 
foresaw that degradation of the material by tissue fluid and subsequent loss of the crystal 
could cause a loss of integrity. This material is not porous and as such, tissue and blood 
vessel in-growth is prevented. The biologic impact of this non-porous nature is not known, 
and only few studies support the use of this material in periodontal and maxillofacial 
procedures (Garg 2004).  
Bioactive glass ceramics have two properties that contribute to the successful results 
observed with its use: (Misch and Dietsh 1993) a relatively quick rate of reaction with the 
host cell and (Marx and Saunders 1986, 347- 428) an ability to bond with the collagen found 
in connective tissue (Kirsh and Garg 1994). It has been documented that the high degree of 
bioactivity may stimulate the repair process and induces osteogenesis (Wilson 1993). 
Because the bioactivity index is high, reaction layers develop within minutes of 
implantation. As a result osteogenic cells in the implantation site may colonize the surface of 
the particles and produce collagen on these surfaces, osteoblast then lay down bone material 
on top of the collagen; an action which may supplement bone that grow by osteoconduction 
from the alveolus. In their seminal clinical trial and subsequent publication of 1993, Schepers 
et al (Schepers, Ducheyne, Barbier and Schepers 1993) reliably demonstrated that bioactive 
glass granules of narrow size range constitute a valuable material to aid in the repair of 
dental bone lesions. 
The phenomenon of osteogenesis guided by bioactive glass particles with a narrow size 
range has been explained. The glass particles and the surrounding tissue fluids result in the 
formation of a silica gel, which is quickly covered by a calcium-phosphorous-rich layer. The 
particle size of the glass is such that the entire granule is transformed into silica gel (i.e. it is 
gelated). Phagocytosing cells penetrate the silica gel by means of small cracks in the outer 
calcium-phosphorous layer and partially resorbs the gel. This resorption leads to the 
formation of protective pouches in which primitive mesenchymal cells acquire phenotypic 
characteristics of osteoblasts. These osteoprogenitor cells adhere to the inner surface of the 
pouch. When the primitive cells are immobilized on this inner calcium-phosperous-rich 
layer (a bone-like surface), differentiation of these cells into osteoblasts occurs. In this way 
islands of new bone tissue are formed without the need for osteoblastic proliferation from 
the preexisting bone (i.e. the cavity walls (Schepers, de Clercq, Ducheyne and Kempeneers 
1991 and Schepers, Ducheyne, Barbier and Schepers 1993). The size range of bioglass 
particles must be narrow (300 to 360 um for the glass composition selected) due to several 
critical considerations (Schepers, de Clercq, Ducheyne and Kempeneers 1991 and Schepers, 
Ducheyne, Barbier and Schepers 1993), the phenomenon of preferential resorption of the gel 
is restricted to this size range. Particles with a size exceeding this range do not corrode 
throughout and therefore are not resorbed into their centers. Hence recruitment of primitive 
cells exhibiting osteoblastic differentiation throughout the bone defect does not occur and 
healing is slow since it must proceed from the pre existing bone tissue walls. Particles with 
smaller diameter are fully resorbed and cannot act as a substrate for enhancement of 
mesenchymal cells. Glass granules preparations that contain the critical 300 to 360mm size 
range and also smaller particles are not active as described. Another critical aspect related to 
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small size range is the packing of the particles (Schepers, de Clercq, Ducheyne and 
Kempeneers 1991 and Schepers, Ducheyne, Barbier and Schepers 1993). When granules have 
uniform dimensions, dense packing will still leave space between the particles. With a wider 
size range, smaller particles fill up the spaces in between the larger particles. Such a 
granular mixture will extensively fill a defect space and leave very little room for tissue 




Fig. 5. Difference in packing when a limited size range of particles is used (A) as opposed to 
a larger size range (B) 
The endosseous ridge maintenance implant (ERMI, US Biomaterials) is another Bioactive 
glass bone substitute. It is a cone-shaped device made of bioglass that is placed in the 
extraction site (Kirsh and Garg 1994). This bone implant system can be used for maxillary 
and mandibular premolars and anterior teeth. It can also be used for preserving the contour 
of the alveolar ridge following tooth removal. This bone implant acts under a time-
dependant kinetic modification of its surface after placement within one hour of 
implantation; a chemical bond appears to form within the bone tissue (Kirsh and Garg 1994). 
Based on a study (Kirsh and Garg 1994), denture wearers showed a retention rate of 
approximately 90% for up to seven years when the Bioglass implants were used for alveolar 
ridge maintenance (Kirsh and Garg 1994). 
Perioglass (Mova Bone, Alachu, FL) is a synthetic particulate form of Bioglass that bond to 
both bone and certain soft connective tissues (Wilson 1993). Perioglass is composed of 
calcium, phosphorous, silicon and sodium (Fetner, Hartigan and Low 1994). The quality and 
quantity of new bone deposition may increase with the use of perioglass particles compared 
with hydroxyapatite crystals (Oonishi 1994). Perioglass is indicated for the treatment of 
intrabony defects and the criteria for successful perioglass use includes pre-treatment 
planning, debridement of the defect, preservation of soft tissue vascularity and infection 
control (Quinones and Lovelace 1997). 
Perioglass has demonstrated two favorable characteristics: ease of compactability and ability to 
promote hemostasis (Fetner, Hartigan and Low 1994). When well packed into osseous defects, 
it becomes strongly adherent and hardens into a solid mass incapable of being disturbed by a 
suction tip or hand piece. Fetner, et al concluded that by bonding to both bone and connective 
tissue, perioglass achieved improved grafting results (Fetner, Hartigan and Low 1994). 
A B 
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Biogran (3i, Implant Innovations, Palm Beach Gardens Fl.) is another resorbable bioactive 
glass bone grafting material which have granules that are chemically identical to perioglass 
and are composed of calcium, phosphorous, silicon, and sodium. The difference between 
perioglass and biogran is the size range of the particles- 300 to 355 um for biogran and 90 to 
710 um for perioglass. Biogran is hydrophilic and slightly homeostatic; it stays in place in 
the defect when bleeding occurs. Once in contact with the patient’s blood, it forms a 
cohesive mass that is shaped into the defect (Garg 2004). Bone transformation and growth 
occurs within each granule. This osteogenesis which is guided by bioactive glass particles 
occurs at multiple sites, rapidly filling the osseous defects with new bone that continuously 
remodels in the normal physiologic manner (Rummelhart, Mellonig, Gray and Towle 1989, 
Schepers 1993 and Duchenyne et al 1992). This bioactivity permits material and bone 
transformation to occur simultaneously. 
Bioplant HTR Polymer (Bioplant, Norwalk, CT) is a microporous composite with a calcium 
hydroxide graft surface (Ashman 1993 and Ashman 1984). This polymer resorbs slowly and 
is replaced by bone after approximately 4 to 5 years. This bone grafting material has been 
reported to be effective for ridge maintenance post extraction, ridge augmentation 
(immediate or delayed) and repair of periodontal and other bone defects. Boyne (Boyne 
1995) concluded that in the HTR-implanted defects, bone tended to become lamellated 
(cortical) in the area of the particulate grafted implant particle over a long period of time. 
This lamellated bone structure suggests that such crestal regions should resist resorption in 
clinical areas. Porous bone material (Bio-Oss, Switzerland) that slowly resorbs and 
remodelled slowly also has been shown to confer a similar resistance to resorption on 
edentulous ridges in clinical situation (Boyne 1991). HTR is non-resorptive and may offer 
the same type of ridge support against resorption. The ability of HTR to produce an 
environment that resists resorption should be determined on a long-term basis by controlled 
clinical studies of conventional and root form implant supported prosthesis. 
Garg  (Garg 2004) argues that the use of autogenous bone, allografts and alloplasts or tissue 
engineered materials, alone or in combination should be based on the osteogenic potential of 
the recipient site. The decision should be based on the individual’s systemic healing ability, 
considering among other things age, systemic illness affecting healing, (such as diabetes or 
autoimmune disorders like scleroderma and lupus), previous surgeries to the area, previous 
radiation treatment or chemotherapy, and irradiated tissue bed.  Local osteogenic potential 
of the defects (e.g. defect size, ratio of host bone to graft material, number of walls of the 
defect, soft tissue bed, adjacent scar tissues, health of adjacent periostium, stability of the 
graft material, soft tissue closure, use of interim restorative device over and around grafted 
site should also be considered. The osteogenic potential of the graft, the surgeon’s skill and 
the time available for graft maturation are also critical to the decision. 
It is as such important at this stage to indicate that the membrane sandwich technique 
allows us to enhance, combine, and maintain osteogenic potential at the required site.  
3. Application of bone grafting materials and selection criteria  
The application of bone grafting materials and selection criteria should be done against the 
background of the understanding  that autogenous bone graft is the gold standard for 
utilization in any peri-implant or periodontal bony defect, because it forms bone by 
osteogenesis and  additionally by osteoinduction and osteoconduction. 
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For the predictable long-term success of dental implants it is important to appreciate the 
available bone (Misch 1990). When available bone is inadequate, bone substitute represent a 
viable treatment modality. The extraction sockets, ridge defects and sites where bone 
volume is inadequate may be filled to maintain or improve ridge anatomy, improve 
esthetics and function, and/ or prepare the site for endosteal implants. Bone graft 
substitutes can also be found beneficial in the treatment of peri-implant defects which may 
occur after or during implant placement. It is important that the composition of the graft 
used to fill defects correspond to the mode of action of the graft material, and the number of 
walls of host bone remaining in contact with the graft (Misch 1993). 
With regards to defects in the oral cavity that may require bone grafting, we have; five-wall 
defects, four-wall defects, two or three-wall defects and one-wall defects; each defect 
requires a particular type or combination of bone grafting substitute for optimum healing. It 
is for this reason that in this Section; I have dealt with bone grafting requirements per defect. 
3.1 Five-wall defect (with one wall missing) 
An extraction socket can be compared with a five-walled pocket (Fig. 6), similarly a cystic 
cavity is comparable to a five-walled pocket. This pocket is expected to fill with new bone 
by appositional growth. In order to maintain the width of the extracting socket and to 
improve the chance of success of future dental implants placement, an extraction socket can 
be filled with inexpensive resorbable calcium phosphate material to prevent the usually 
documented percent to 60% of the width of the ridge resorption which primarily occurs 
from the facial dimension (Khan et al 1981). 
 
 
Fig. 6. Five-wall defects such as at tooth extraction socket or cystic cavities are filled with 
inexpensive resorbable calcium phosphate material to maintain ridge width.  Autogenous 
bone is least indicated, but may always be used when readily available, since it is an 
osteogenic material and has no cost. 
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Autogenous bone may be used in any defect. It is often readily available without any cost to 
the clinician and forms bone by osteogenesis. When the harvesting site for bone is difficult 
to access, the five-wall defect may be grafted with any resorbable material, and then covered 
with a collagen or synthetic membrane to contain the resorbable material, particularly in 
situations where complete approximation of the soft tissue is not possible. With this 
procedure, it is advisable that 4 to 6 months elapse before re-entry and implant placement 
(Misch and Dietsh 1993). 
3.2 Four-wall defect (defect with two walls missing) 
If the host bone site has lost an additional wall of bone (usually the labial wall), it is called a 
four-wall defect. Additional active elements are beneficial in this graft since bone does not 
surround the defect.  In such cases the addition of DFDB to the alloplastic calcium 
phosphate is recommended in order to compensate for the lack of labial bone and additional 
soft tissue in approximation to the graft (Roberts et al. 1987). It is suggested that the calcium 
phosphate be mixed with DFDB and over packed or contoured beyond the defect and this 
material is covered further with DFDB. This will allow the DFDB to be intact with the 
overlying soft tissue to modify the undifferentiated cells into osteoblast (Fig. 7). 
 
 
Fig. 7. With four remaining walls (usually labial and occlusal walls missing), calcium 
phosphate mixed with DFDB is placed over the host bone to retard soft tissue ingrowth. 
DFDB is placed on top of the calcium phosphate mixture so it is close to soft tissue for an 
osteoinductive effect. 
The calcium phosphate acts similar to a barrier (due to its bulk) to retard the amount of soft 
tissue in growth within the graft and allows more bone formation in the region. DFDB when 
used alone in defects has not yielded much satisfactory results since it is eliminated too 
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rapidly to permit a predictable volume of bone formation in the defect with the four- wall 
defect as such a healing period of at least 6 months should elapse before implant placement 
(Misch and Dietsh 1993). 
3.3 Two or three-wall defect (defects with 3 or 4 walls missing 
The loss of three or four bony walls will create a two or three wall defect. This type of defect 
requires the use of autogenous bone. The autogenous bone can be harvested intraorally 
from the maxillary tuberosity or with a trephine drill under the roots of the mandibular 
incisors and is positioned in the defect in contact with the host bone. Such placement allows 
for blood supply from bone to be established, to maintain trabecular cell survival. DFDB is 
laid over the autogenous bone chips to begin the osteoinduction process. Calcium 
phosphate and DFDB are added on top and the entire graft is covered with a membrane. A 
resorbable membrane is preferred to prevent the need for early re-entry and to reduce the 
risk of infection.  Overall this approach allows guided tissue regeneration technique to 
impair epithelial in growth into the graft which would otherwise impair the healing process. 
Although the two-three wall defects are larger, the healing time is more rapid with the 
autogenous bone component. In approximately six months the implant can be inserted 
(Misch and Dietsh 1993) (Fig. 8). 
 
 
Fig. 8. The loss of three to four bony walls (a two or three wall defect) necessitates the use of 
autogenous bone 
3.4 One-wall defect 
Defects with five missing walls (one-wall defect) warrant the use of an autogenous 
corticotrabecular bone to regenerate a good volume of bone in the recipient site. A block 
graft is therefore the most preferable approach. The cortical aspect of the block is placed 
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superiorly to act as a barrier to the invergination of the soft tissue within the graft. A 
mixture of chips of autogenous bone, then DFDB and then calcium phosphate and DFDB 
can be used to fill any defects around the block of the bone (Fig. 9). 
 
 
Fig. 9. Showing a one-wall   defect 
A healing period of four to six months is adequate to permit ridge reconstruction since 
autogenous bone is the major component of the graft (Misch and Dietsh 1993 and Misch 1993). 
If the cortical bone is present on the superior aspect of the autogenous graft, the area may be 
covered with a thin DFDB sheet or small pore membrane to prevent soft tissue ingrowth.  
4. The indications for uses of bone substitutes 
In implant dentistry the indications for use of bone substitutes can be divided into: 
a. Pre-implant bone grafting needs such as: 
i. Ridge augmentation 
ii. Maxillary sinus lift procedure 
iii. Extraction socket for delayed implant placement 
iv. Extraction socket for ridge preservation 
v. Intrabony defect  
vi. Furcation involvement of teeth adjacent to implant site 
vii. Recession 
viii. Pneumatized sinus 
b. Intra-implant surgery bone grafting needs such  
i. Intra-operative per-implant placement ( precautionary of mandatory) 
ii. Extraction socket during immediate implant placement 
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iii. Repair of cortical bone plate dehiscence 
iv. Alveolar or mental nerve protection 
v. Conventional maxillary sinus lift procedure 
vi. Osteotome technique for maxillary sinus lift  and simultaneous implant placement 
vii. Ballooning technique for maxillary sinus lift and simultaneous implant placement 
viii. Intra-operative ridge preservation 
ix. Furcation involvement, recession and intrabony defect of teeth adjacent to the 
implant site. 
c. Post –implant bone grafting needs such as; 
i. Implant failure 
ii. Peri-implantitis 
The repair of defects around previously inserted endosteal implants can also be performed 
with bone substitutes. At the time of uncovering, defects and bone resorption are best 
identified around the implant with a full-thickness reflection. The defect filled with soft 
tissue can be curetted and filled with autogenous bone. The defect is then covered with 
DFDB since such defects are similar to three or four wall defects (Misch and Dietsh 1993). 
Subantral augmentation after sinus elevation in the posterior maxilla is the most predictable 
region of the oral cavity where the atrophic ridge can be augmented in height with the use 
of allografts and alloplastic material (Misch and Dietsh 1993). Autogenous bone is an 
excellent material for this procedure, but the quantity of bone necessary to fill the antrum 
often requires harvesting host bone from an extraoral site. The procedure has been further 
modified to permit the use of less autogenous bone and incorporation of both allografts and 
alloplastic  materials. Results from structures show that the subantral region is similar to a 
three or four-wall defect and the graft should include autogenous bone, DFDB and TCP or 
microporous HA to combine osteogenic, osteoinductive and osteoconductive modes of bone 
regeneration (Misch and Dietsh 1993). 
The fact that the last fifteen years have seen the introduction of several bone substitutes. 
Those materials can modify the bony structure of the patient prior to implant treatment, 
during implant treatment and after dental implant treatment. It is as such very important to 
understand the characteristics of the different materials in reference to crystallinity, 
porosity, particle size, chemical structure, and PH in order to be able to select the most 
appropriate type or combination to achieve a predictable result. 
5. Validation of bone substitutes (second-hand bone) 
Bone substitutes are best validated utilizing single photon emission computerized 
tomography (SPECT)TO disclose in a dynamic way the osteoblastic activity and calculated 
index around the bone grafting site over a period of time . It is the intention of this section to 
explain SPECT and its various applications and then to describe the SPECT experiment to be 
used to a compare second hand bone such as Bio-Oss  with autogeneous bone ( both of 
which are contained in the Ogunsalu sandwich  unit). 
5.1 Single Photon Emission Computerized Tomography (SPECT) 
The literature is replete with the various applications of single photon emission 
computerized tomography (Khan et al. 1980, Ell et al. 1981, Flood and Russel 1998, Lima et 
al. 2004, Van der Wall and Fogelman 2007,  Horger and Bares R. 2006, Schafers and Stegger 
2008, Dasgeb Mulligan and Kim 2007, Sarikaya, Sarikaya and Holder 2001, Ozyurt et al. 
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2008, Kalita et al. 2008 Crespo et al. 2008, Massardo et al. 2008 and Ellis et al. 2008), however, 
there is a dearth of information on the applications of SPECT in relation to implant 
assessment and osseointegration .Reports in the medical literature on the radiologic 
evaluation of per-implant bone changes in the context of osseointegration are limited to one-
dimensional quantitaions of heights of the defects. Despite the fact that digitized 
radiography and computerized tomography can facilitate quantification of bone changes, 
these methods generally reflect morphologic changes but may fail to detect the dynamics of 
osteoblastic activity (Massardo et al. 2008, Ellis et al. 2008, Alberto 1998 and Galasko 1975). 
Bone scintigraphy which is a well established imaging technique that accurately reflects 
osteoblastic activity (Ogunsalu et al. 2008) can be utilized to radiographically assess 
osseointegration. In most clinical situations, the data from planar or conventional 
radiographic views are usually sufficient for diagnosis, but accurate quantitative analysis 
may not always be possible because of interference by superimposed structures. The single 
photon emission computerized tomography (SPECT) provides an additional refinement to 
planar imaging, it allows accurate quantitation common to most tomographic techniques by 
removing regions not of clinical interest. 
Although the  SPECT technique is well established and successful in clinical application for 
the study of many organ systems, (including skeletal system) (Khan et al. 1980, Ell et al. 
1981, Flood and Russel 1998, Lima et al. 2004, Van der Wall and Fogelman 2007,  Horger 
and Bares R. 2006, Schafers and Stegger 2008, Dasgeb Mulligan and Kim 2007, Sarikaya, 
Sarikaya and Holder 2001,  Ozyurt et al. 2008, and Kalita et al. 2008), its application by 
clinicians and manufacturers alike have been very much non- existent in the clinical or 
experimental assessment of osseointegration of bone grafts and implant systems.  Recently 
however, Ogunsalu and co-workers have utilized SPECT to successfully assess 
osseointegration of a new bone grafting/ regeneration technique (Ogunsalu et al. 2008 and 
Ogunsalu et al 2008) and also for comparative assessment of osseointegration relating to 
implant systems (Ogunsalu et al. 2008 and Ell et al. 1982). 
The underlying principles of SPECT are common to most tomographic imaging techniques. 
When a radiopharmaceutical agent containing a single gamma-photon emitting 
radionuclide such as technetium 99m is injected intravenously it is possible to obtain a 
three-dimensional representation of the distribution of radioactivity within an organ or an 
area of interest in which  the radiopharmaceutical agent  is localized by using radiation 
detectors and rotating gamma cameras which detects the emitted radioactivity as the camera 
is rotated around the clinical or experimental area of interest. The acquired data can then be 
processed by a computer which will initially provide a cross-sectional (trans-axial) 
representation of the distribution of radioactivity. The transaxial data can additionally be 
used to reconstruct sagittal and coronal images.  
It is the ability for multiplane image reconstruction with SPECT which confers greater 
diagnostic accuracy to SPECT. Additionally, SPECT permits accurate volumetric 
measurement and it is thus possible, for quantitation of the distribution of radioactivity in 
terms of Mci per unit volume of tissue (Khan et al. 2000).  This unique ability to quantitate 
physiologic events, by using a bone-seeking radiopharmaceutical sets SPECT apart from 
other tomographic techniques such as computerized tomography (Khan et al 2000). CT 
Scans (computerized tomography) is able to provide excellent morphological details but 
unlike SPECT, it is unable to provide functional data. 
In a highly significant publication, Khan et al (Khan et al 2007 and Ogunsalu 2007) described 
SPECT as capable of accurate quantitation of bone changes, before and after titanium dental 
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implants in edentulous patients. “A novel approach that has the value in imaging bone 
changes dynamically and further offers an objective method for monitoring such dynamic 
changes before, during and after implantation” (Khan et al 2007). 
6. Experiment  
6.1 Materials and methods 
Experimental Animals 
Seven pigs 4 months old and weighing between 25 and 30 kg (Fig.10) were used. Pigs were 
used for this experiment because of the similar metabolism to human and the ease of ethical 
approval which should have been problem if dogs were used for obvious reasons. The pigs 
were all obtained from the same swineherd and, as far as possible, from the same litters.  
The pigs were housed at holding pens (Fig. 10) in the School of Veterinary Medicine for a of 
2-3 week period of acclimatization prior to the surgery.  
On the day of surgery, each pig was pre-anaesthetised with Azaperone (Stresnil,) and 
Butophanol at the dose rates of 6mg/kg and 0.2mg/kg respectively, induced with 5% 
Thiopentone at 10 mg/kg, intubated and maintained with isofluorane in oxygen. An 
Omicron Plus Multiparameter monitor was used to evaluate the vital parameters, including 
ECG, heart rate, pulse rate, invasive arterial blood pressure, respiratory rate, Sp02, and end 
tidal CO2.  The anaesthetized pig was placed in dorsal recumbency and the mandibular area 
was prepared for surgery by clipping the hair, thorough washing with chlohexidine surgical 
scrub solution (Hibitane) followed by two alternating applications of povidone iodine and 
surgical (70%) alcohol. 
 
 
Fig. 10. Showing a 4 month old pig weighing approximately 30kg being cleaned and 
prepared for the operating room 
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Fig. 11. Showing the operating room set-up and operator at work on the appropriately 
draped animal. 
Surgical procedure 
The animal was then drapped as shown in Figure 11 prior to making an incision 
(approximately 6 cm long) along the ventro-lateral aspect of the mandible just cranial to the 
masseter muscle.  The incision was extended to the subcuticular muscles to expose the 
mandible without damaging the facial artery.  A self-retaining retractor was used to allow 
adequate exposure of the bone.  An area measuring approximately 17 mm by 16 mm was 
marked on each mandible (left and right) using a template, and a block of bone measuring 
approximately 17 x 16 x 4 mm was removed from each mandible using an Elcomed implant 
surgical motor and a surgical fissure burr at a speed of 18000rpm (NI).  The appropriate 
graft (with or without the sandwich) were placed in the appropriate mandibular defect.  
Subcutaneous tissue was then closed with Vicryl (0), and the skin closed with #3 Vetafil.  
The Sandwich 
The sandwich is prepared as shown in Figure 12 below. Two sheaths of restorable 
membrane (Bio-Gide) are utilized and tailored with a restorable suture material into a 
pillowcase before the particulate bone grafting material (Bio-Oss) is placed in it. The 
tailoring was completed by suturing the fourth side with the same suture material to 
produce a closed sandwich unit ready to be implanted in the surgical site. 
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Fig. 12. The creation of the sandwich unit with Bio-Gide, Bio-Oss and resorbable sutures. 
Evaluation of bone regeneration and ossification 
Bone regeneration and osseointrgration were evaluated by (a) Computer Assisted 
Tomography scan (CT scan), (b) Single Photon Emission Computerized Tomography 
(SPECT), and (c) Histological and Histomorphometric techniques.  
Single Photon Emission computerized tomography (SPECT): 
SPECT studies focused primarily on evaluating the osteoblastic activities, especially the 
vascularization in and around the site of the graft or region of interest (ROI) At the end of 
each implantation period, the pig was anaesthetized and given an intravenous injection  
(into the ear vein) of 740MBq (20 mci) technetium 99m-methylene diphosphate.  The pig was 
subsequently euthanized two and half hours after the injection and then the mandible was 
removed. Tomographic images of the mandible in the region of interest (ROI) were acquired 
within 30 minutes of removal, using a Semens Orbiter II rotating large field-of-view gamma 
camera equipped with a low energy high resolution Collimater (Siemens Medical System 
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Inc, Erlangan, Germany).  A total of 64 projections images (205/images) were acquired over 




Fig. 13. The nuclear imaging team at work around the gamma camera and pigs mandible. 
From the left, Dr John Watkins, Mr Anthony Archibald and Dr Christopher Ogunsalu. 
7. Results 
7.1 Study I 
SPECT Evaluation 
The SPECT images demonstrated higher radioactivity on the right mandible compared to 
the left mandible, this indicates higher take-up of the radioactive material, which translate to 
higher osteoblastic activity. As such, on can conclude that the side with the autogenous graft 
(right side) has higher osteoblastic activity as shown in Figure 14. This result is presented 
graphically in Figure 15  which shows higher peak on the autogenous bone sandwich side 
compared with the xenograft sandwich side (left side). The average counts were 99.7 pixel 
and 78.1 pixels respectively (table 2) and a calculated relative activity ratio of 1:20. 
 





1.  Right 
mandible 
a.  Membrane –  Bio-Gide ®
b.  Bone substitute – autograft
112 99.7 11167 
2.  Left 
Mandible 
a.  Membrane – Bio-Gide ®
b.  Bone substitute – xenograft (Bio-OSS®)
129 73.1 9425 








Fig. 14. Illistration of osteoblastic activity for Pig 1 at 14 weeks. 
 
 
R = Right side 
Fig. 15. Showing graphically the profile of osteoblastic activity of the autogeneous sandwich 
side (right side) versus the Bio-Oss sandwich side (left side), together with the activity ratio. 
The autogenous sandwich side obviously has more activity than the Bio-Oss sandwich side 
(note that the actual left side of the pigs jaw is represented by the right side of the profile). 
R 
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The CT-scan evaluation also depicted the morphological state of  the bone regeneration site 
with the side which utilized the autogenous bone with the sandwich side having much more 






Fig. 16. (a- top and b- bottom): CT Scan showing the transverse saggital slices in the area of 
bone regeneration. Note the regular recortication on the side with autogenous sandwich 
(right side), compared with the side with Bio-Oss sandwich (left side), which shows less 
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8. The proper use of bone replacements 
As mentioned earlier on in the chapter, bone replacement can be either autogenous in origin 
or non-autogenous and as such called second-hand bones or bone substitutes. 
The proper use of the autogenous bone begins with its harvesting either as particulate, block 
or core graft to be placed in the site that requires bone to be regenerated.  Recently the 
disposable bone scrappers became available in the market for the harvesting of particulate 
autogenous bone (Fig. 17). The attached CD will assist the clinician who is not 











Fig. 17. Disposable bone scrapper for harvesting of particulate bone 
Because of the technique sensitivity ascribed to the use of particulate bone substitute and the 
fact that it is the most common forms of bone substitute used in implant dentistry today, I 
will in stages describe the use of Bio-Oss (Osteohealth, Shirley, NY) particulate bone 
substitute in a furcation involvement in the mandibular molar region. 
Bio-Oss (Fig. 18 and Fig. 19) is a xenogenic second hand bone obtained from bovine source 
and distributed in sterile packs and more important is the fact that it is sold only to 
practioners with current annual practicing license. 
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Fig. 19. Bottle of Bio-Oss particulate bone substitute(Xenograph) 
In implant dentistry or in periodontal bone reconstruction or regeneration, it is best used 
with the resorbable membranes (Fig. 20 and 21 )consistent with the guided tissue 
regeneration (GTR) technique. 
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Fig. 20. Bio-Gide resorbable membrane(smooth side) 
 
 
Fig. 21. Bio-Gide resorbable membrane(rough side) 
Once the surgical site has been exposed and  all granulation tissue has been removed from 
the periodontal pathologic pockets and furcation area as shown in Figure 22 and 23. 
 
 
Fig. 22. Surgical site with some granulation tissue mesial to first molar tooth 
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Fig. 23. Surgical site with all granulation tissue removed 
The particulate bone which has been soaked with the patient’s blood or sterile water is now 
condensed into the defect utilizing an amalgam plugger dedicated only for use in bone 





Fig. 24. Condensation of bone substitute with amalgam plugger 
Once the particulate bone has been packed into the bony defect and appropriately 
condensed, the autotac pins and kit (Fig. 25) is now used to secure the GTR membrane 
which has been used to cover the grafted site (Fig. 26). 
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Fig. 26. Grafted site covered with resorbable membrane which is secured with stainless steel pins 
The surgical procedure is then completed by suturing preferably with a non-resorbable 
suture material in such a manner that it is tension free (Fig. 27) 
 
 
Fig. 27. Tension free suturing with resorbable suture 
Most manufacturers of bone regenerative materials proudly explain the stage by stage use of 
their products in the appropriate section of their website. These information for use should 
be considered as very reliable and the clinician intending to use these products must adhere 
strictly to the suggested surgical sequence.  For example Straumann, the manufacturers of a 
bone substitute, Emdogain proudly describe the use of this product which come in gel form 
variably by audiovisual on its website, www.straumann.us.index/.../products-emdogain.htm. 
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Additionally they also mention the functional advantage, cellular process involved in bone 
regeneration when Emdogain is used . The various scientific research to back-up this 
product is also mentioned. 
9. Osteobstruction and bone substitutes 
The osteobstruction mechanism in bone regeneration was coincidentally discovered during 
a sequential SPECT, histological and histomorphometric analysis on animal model in the 
validation of the Ogunsalu Sandwich Bone Regeneration Technique (Ogunsalu 2009). 
This osteobstructive mechanism was demonstrated  by episodes of overtaking and re-
overtaking on SPECT  following evaluation of osteoblastic activities in a sequential animal 
experiment to validate both  the Ogunsalu Sandwich Bone Regeneration Technique (a 
double guided tissue technique; D-GTR) and the interceed membrane technique (a single 
guided tissue regeneration technique-;S-GTR) utilizing SPECT, histological and 
histomorphometric evaluation (Ogunsalu et al. 2008).  
This new phenomenon of overtaking and re-overtaking and the newly discovered 
osteobstructive phenomenon, in bone regeneration are integral finding of my experiment, of 
which much discussion will follow in the next paragraph which will focus primarily on 
discussing the findings of sequential histological and histomorphometric findings, against 
the background of the SPECT findings at 8, 14,11,17,13 and 24 weeks. The implications of 
this sequential finding will also be discussed. 
During the 8th week the total bone area was slightly more in the interceed side than the 
sandwich side and both side had vital bone with no non-vital bone. Also the marrow and 
fibrous tissue was more on the interceed side. This is in keeping with the superior osteoblastic 
activity on the interceed side on SPECT when compared with the sandwich side (Fig. 28) 
 
 
Fig. 28. Showing graphically the profile of osteoblastic activity of the sandwich side (SS) 
versus the interceed side (IS), together with the activity ratio. The IS obviously has more 
activity than the SS at 8 weeks. Note that the actual left side of the pig is represented by the 
right side of the profile. 
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Fig. 29. Showing graphically the profile of osteoblastic activity of the sandwich side (SS) 
versus the interceed (IS) together with the activity ratio at 11 weeks. The interceed side still 
leads the SS at Fig 29: 11 weeks. Note that the actual left side of the pigs jaw is represented 
by the right side of the profile. The osteoblastic activity is still superior on the interceed side. 
 
 
Fig. 30. Showing graphically the profile of osteoblastic activity of the sandwich side (SS) 
versus the interceed side (IS) together with the activity ratio at 13 weeks. The osteoblastic 
activity in the sandwich side has now overtaken the interceed side (slightly) at 13 weeks. 
Note that the actual left side of the pigs jaw is represented by the right side of the profile. 
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Fig. 31. Showing graphically the profile of osteoblastic activity of Sandwich side (SS) versus 
interceed side (IS) together with the activity ratio. The IS still leads the SS in terms of 
osteoblastic activity at 17 weeks as a result of an overtake. Note that the actual left side of 
the pigs jaw is represented by the right side of the profile 
 
 
Fig. 32. Showing graphically the profile of osteoblastic activity of the sandwich side (SS) 
versus interceed side (IS), together with the activity ratio at 24 weeks. The sandwich side has 
finally exceeded the interceed side at 24 weeks.  
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The superiority of the interceed side was short lived at week 13 due to an overtake by the 
sandwich side (Fig. 29 to Fig. 32). This overtake as we found was due to the presence of 
foreign body reaction on the interceed side at week 11 as shown in Figure 33. The foreign 
body reaction is what can cause osteobstruction during bone regeneration. We as such 
include this as part of the mechanism of bone regeneration depite it being a negative 
mechanism when compared with osteogenesis, osteoinduction and osteoconduction which 





NB = New Bone, ST = Soft Tissue, FB = Foreign Body, WOFB = Walling off of foreign body 
Fig. 33. Medium power photomicrograph showing Bio-Oss in soft tissue representative if 
foreign body reaction. (Slide 22-06-49M; Stevenel’s blue and van Gieson’s picro fuchsin) 
10. Conclusion 
Various bone grafting substitutes continue to emerge into the market to assist with bone 
regeneration prior to, during and after implant therapy. These bone grafting substitutes 
preferably called second hand bones should be classified as shown in Figure 3. They can 
only be validated quantitatively and qualitatively by the monitoring of the triggered 
osteoblastic activity over a time period utilizing single photon emission computerized 
tomography(SPECT) as demonstrated in the work of Ogunsalu and co-workers.It is this 
validation that will inform the clinician which bone substitute performs better in terms of 
bone regeneration and osteoblastic activity/ index. Further more, the osteo-obstructive 
phenomenon in bone regeneration discovered by the above mentioned workers is new and 
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